Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127009441 | 12700944 | 1 | I | 201311 | 20160825 | 20160831 | 20160831 | EXP | US-ASTRAZENECA-2016SE91998 | ASTRAZENECA | 897.00 | MON | F | Y | 85.70000 | KG | 20160831 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127009441 | 12700944 | 1 | PS | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 100 MG, 1 TABLET IN THE MORNING AND 1 TABLET IN THE EVENING | 19962 | MODIFIED-RELEASE TABLET | |||||||||
| 127009441 | 12700944 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 127009441 | 12700944 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 127009441 | 12700944 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 127009441 | 12700944 | 5 | C | XARELTO | RIVAROXABAN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127009441 | 12700944 | 6 | C | POTASSIUM | POTASSIUM | 1 | Oral | 0 | 10 | MEQ | QD | ||||||||
| 127009441 | 12700944 | 7 | C | RESTORIL | TEMAZEPAM | 1 | Oral | 7.5MG UNKNOWN | 0 | 7.5 | MG | ||||||||
| 127009441 | 12700944 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 75, DAILY | 0 | |||||||||||
| 127009441 | 12700944 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127009441 | 12700944 | 10 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 0 | 240 | MG | QD | ||||||||
| 127009441 | 12700944 | 11 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000.0MG UNKNOWN | 0 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127009441 | 12700944 | 1 | Blood pressure abnormal |
| 127009441 | 12700944 | 2 | Blood cholesterol increased |
| 127009441 | 12700944 | 3 | Blood cholesterol increased |
| 127009441 | 12700944 | 4 | Hypertension |
| 127009441 | 12700944 | 5 | Blood disorder |
| 127009441 | 12700944 | 6 | Cardiac disorder |
| 127009441 | 12700944 | 7 | Sleep disorder |
| 127009441 | 12700944 | 8 | Thyroid disorder |
| 127009441 | 12700944 | 9 | Fluid retention |
| 127009441 | 12700944 | 10 | Cardiac disorder |
| 127009441 | 12700944 | 11 | Herpes virus infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127009441 | 12700944 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127009441 | 12700944 | Atrial fibrillation | |
| 127009441 | 12700944 | Cardiac failure congestive | |
| 127009441 | 12700944 | Drug dose omission |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127009441 | 12700944 | 1 | 2013 | 0 | ||
| 127009441 | 12700944 | 2 | 2006 | 0 | ||
| 127009441 | 12700944 | 6 | 2013 | 0 | ||
| 127009441 | 12700944 | 9 | 2013 | 0 | ||
| 127009441 | 12700944 | 10 | 2013 | 0 | ||
| 127009441 | 12700944 | 11 | 1985 | 0 |